International Business Strategy

Master in International Management

Showing posts with label biogenerics. Show all posts
Showing posts with label biogenerics. Show all posts

Friday, October 2, 2009

Biopharmaceuticals: Availability, diffusion, sustainability

A speech I gave at OECD Workshop on Biotechnology Outputs and Impacts back in 2006 urging a new legislation allowing for approval of biosimilar drugs:

www.oecd.org/dataoecd/17/57/37838005.pdf


Bookmark and Share
Posted by massimo riccaboni at 10/02/2009 01:48:00 AM 1 comment:
Labels: biogenerics
Older Posts Home
Subscribe to: Posts (Atom)

My Blog List

  • HarvardBusiness.org
    Embrace AI Without Damaging Trust: Lessons from the “Financial Times”
    1 day ago
  • The Wine Economist
    Resilience! Changing Times Test Oregon Wine
    1 week ago
  • My Business Musings
    legale Anbieter im Vergleich
    2 months ago
  • The Airline Blog
    More on Baltia Airlines
    16 years ago
  • Is the U.S. Killing Its Innovation Machine?

Blog Archive

  • October (1)
  • March (1)
  • October (10)
  • December (3)
  • November (3)
  • October (18)

Followers

Massimo Riccaboni, http://riccaboni.weebly.com. Watermark theme. Powered by Blogger.